Physician profile
Linn Leclair
NPI 1477913671
$2,720.91
in general payments reported to CMS, 2019-2025
17 companies · $801 in 2025
The $801 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $330 · 2022: $855 · 2023: $536 · 2024: $199 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $837.99 | 2021-2023 | |
| Novo Nordisk INC | $225.57 | 2021-2022 | |
| Alkermes, INC. | $210.24 | 2022 | |
| Globus Medical, INC. | $176.46 | 2025 | Senza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $169.84 | 2022-2023 | |
| Genzyme Corporation | $128.95 | 2025 | |
| Axsome Therapeutics, INC. | $127.65 | 2023 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $126.36 | 2025 | Airsupra |
| Kowa Pharmaceuticals America, INC. | $122.28 | 2025 | Zoryve |
| Amgen INC. | $120.53 | 2025 | Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.85 | 2024 | Jardiance |
| Teva Pharmaceuticals USA, INC. | $107.54 | 2025 | Uzedy |
| Janssen Pharmaceuticals, INC | $92.57 | 2023 | Xarelto |
| Neurocrine Biosciences, INC. | $80.81 | 2024 | Ingrezza |
| Grt US Holding, INC. | $44.21 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $19.16 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Orexo US, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linn Leclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.